Fig. 1 Effects of ONOO− on viability of myotubes. Myotubes were exposed to 25 μM ONOO− for 1, 2, and 6 h. Untreated myotubes served as control (CTL). Following incubation,…
Before Mec/Sal After Mec/Sal 30 min 30 1 h 2 h 3 h 4 h 5 h Mean airway pressure (MAP, kPa) Sal 0.26 ± 0.02 0.59 ± 0.05 0.55 ± 0.03 0.58 ± 0.03 0.55 ± 0.01 0.51 ± 0.03 0.54 ± 0.04 0.57 ± 0.03 Mec 0.30 ± 0.01 0.91 ± 0.03c 0.97 ± 0.04c…
Age, year 67 ± 4.6 BMI, kg/m2 28.6 ± 3.0 Blood pressure systolic/diastolic (mmHg) 136 ± 23/84 ± 15 Fasting glucose (mg/dL) 97.1 ± 14.0 Creatinine (mg/dL) 0.8 ± 0.2 Data are means ± SD BMI body mass index 2.3 Experimental Design The study…
OSA (n = 23) OH (n = 18) Age (yr) 57.9 ± 6.6 56.6 ± 6.6 Weight (kg) 117.7 ± 23.5 127.9 ± 18.3 Height (m) 1.70 ± 0.09 1.76 ± 0.10* BMI (kg/m2) 41.7 ± 6.6 41.4 ± 7.0 ESS (points) 8.0 ± 3.2 11.7 ± 6.0 PaCO2 (mmHg) 41.3 ± 3.7 49.5 ± 3.7** HCO3…
Age (year) 23.2 ± 0.2 Body mass index (kg/m2) 20.9 ± 0.5 Waist-to-hip ratio 0.80 ± 0.01 Percentage fat (%) 23.6 ± 1.6 Data are means ± SE 2.2 Protocol All subjects were examined under standard conditions: a quiet room…
Never-smokers (n = 1,178) Active smokers (n = 777) p Smoking status (pack-years) 0 30.0 (15.0–43.2) Age (year) 65.3 ± 10.1 56.2 ± 10.3 <0.001 Male Gender (%) 45.4 77.9 <0.001 BMI 27.4 ± 4.2 27.0 ± 4.2 0.833a LDL-C (mg/dl)…
Fig. 1 Experimental paradigm. A treatment administration, PA post-administration, Mec meconium, NAC N-acetylcysteine, SAL physiological saline, i.i. intratracheal, i.v. intravenous All animals were oxygen-ventilated for additional 5 h after the treatment….
Never-smokers Active smokers p Number 1,178 777 Smoking (pack years) 0 30.0 (15.0–43.2) Age 65.3 ± 10.1 56.2 ± 10.3 <0.001a Male Gender (%) 45.4 77.9 <0.001b BMI 27.4 ± 4.2 27.0 ± 4.2 0.833a LDL-C (mg/dl)…
